Most leading US publicly traded managed care insurers increased their full-year earnings estimates after reporting second quarter 2026 results. This comes despite facing higher medical costs and shifts in membership, especially within Medicare Advantage plans focused on seniors. The trend of rising medical expenses has continued from 2025 into 2026, impacting insurer operations. However, the positive earnings outlook suggests these companies are managing challenges effectively, which could influence investor confidence going forward.
Solana's Agave 4.2 upgrade, activated on mainnet starting August 17, 2026, introduces three key improvements: a 90% reduction in on-chain storage rent, a 3.3-fold increase in maximum transaction size, and a staged reduction of slot time from 400ms to...
StoneCo reported disappointing Q2 results with revenue growing only 2.5% year-over-year and earnings per share falling short of expectations. The company is increasingly relying on credit services to drive growth, but rising delinquencies raise conce...
Zoetis is experiencing its worst stock decline ever, down 70% from its peak, due to weaker U.S. veterinary clinic visits and increased competition in key animal health segments. Despite aggressive competitor promotions, Zoetis maintains strong profit...
Rhythm Pharmaceuticals is evolving from a single rare disease drug company to a broader therapeutic franchise focused on MC4R treatments. Their drug IMCIVREE has gained approval for AHO and shows strong demand with over 400 patient starts, supported ...
Google plans to relocate all Pixel device manufacturing from China to Vietnam and India by 2027, aiming to reduce supply chain risks amid US-China trade tensions. This move follows Samsung's lead and supports Google's goal to increase Pixel shipments...
